ReachRxResearch
Home
Research
Sign Up
Association between estimated glucose disposal rate and benign prostatic hyperplasia: results from two nationally representative population-based studies
Back to Research Hub
  1. Home
  2. Research Hub
  3. Association between estimated glucose di…

Association between estimated glucose disposal rate and benign prostatic hyperplasia: results from two nationally representative population-based studies

The Aging Male·August 25Open Access
Endocrinology & MetabolismUrology & NephrologyLimited evidenceBenign Prostatic HyperplasiaInsulin ResistanceCross-Sectional StudyMetabolic BiomarkerOlder Adult

Summary

View source

What was studied

This cross-sectional analysis examined the association between estimated glucose disposal rate (eGDR) — a proxy for insulin resistance — and benign prostatic hyperplasia (BPH) in older men from two large national cohorts: CHARLS (China) and NHANES (USA).

Key findings

Higher eGDR was inversely associated with BPH risk in both populations (CHARLS: n=4,382; NHANES: n=3,463), with a significant linear dose-response relationship on restricted cubic splines. Monocytes partially mediated the eGDR–BPH relationship in NHANES, accounting for −15.14% of the effect (p < 0.0001).

Study limitations

Cross-sectional design prevents causal inference. BPH ascertainment methods may differ between CHARLS and NHANES. eGDR is an estimate of insulin sensitivity, not a direct measure, which may introduce measurement error.

Clinical implications

Improving insulin sensitivity — reflected by higher eGDR — may be associated with lower BPH risk in older men. Clinicians managing metabolic health in aging males may consider BPH as a related comorbidity worth monitoring.

Caveats

  • eGDR is a calculated surrogate for insulin sensitivity, not a direct metabolic measurement — results may not fully reflect true glucose disposal capacity.
  • Mediation analysis by monocytes was only performed in the NHANES cohort; replication in CHARLS was not reported.
  • The combined sample size (n=7,845) pools two distinct cohorts with potentially different BPH diagnostic criteria and demographic profiles; cross-cohort comparisons should be interpreted cautiously.

Related Questions

Explore related topics

What is the relationship between insulin resistance and benign prostatic hyperplasia risk in older men?How does metabolic syndrome affect BPH development and progression?Can improving insulin sensitivity reduce lower urinary tract symptoms in aging males?

Publication Details

Year
2026
Journal
The Aging Male
Sample Size
n=7,845
Source
View article
Keep scrolling
More content below.
Up Next